iStock-534890661.jpg

Our Pipeline

OUR PIPELINE

Dragonfly's novel cytokines and "TriNKET" NK cell engagers can both kill cancers and other disease targets directly, and improve the outcomes of other immunotherapy approaches like T-cell therapies.

Our initial pipeline includes a range of disease targets from cancers to  

DISCOVERY

LEAD SELECTION

FILE IND

PHASE I

Dragonfly Solid Tumor Target DF1001

Dragonfly Heme Tumor Target DF2001

Dragonfly Heme Tumor Target DF3001

Dragonfly Heme Tumor Target DF4001

Dragonfly Heme Tumor Target DF5001

Dragonfly Cytokine DF6000